VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma

BACKGROUND: The combination of vincristine, irinotecan, and temozolomide (VIT) is often used to treat children and adolescents with relapsed rhabdomyosarcoma (RMS); however, the outcome of these patients has not been previously described. PROCEDURES: We sought to determine the response rate (RR) and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: Setty, Bhuvana A., Stanek, Joseph R., Mascarenhas, Leo, Miller, Alexandra, Bagatell, Rochelle, Okcu, Fatih, Nicholls, Lauren, Lysecki, David, Gupta, Abha A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7497851/
https://ncbi.nlm.nih.gov/pubmed/28748602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.26728
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados